Pfizer broke ground on its new Andover, MA-based biologics clinical manufacturing facility this week, which will feature single-use and disposable technologies.
How have single-use technologies changed drug production? How do you dispose of a disposable technology? What will drive the market going forward? EMD Millipore answered these questions and more at Interphex 2011.
Pall Life Sciences has launched its Allegro 3D biocontainers, which have been designed to improve the performance of the company’s large-scale, single use manufacturing systems.
The use of disposable manufacturing equipment in pharmaceutical
production and greater need for containment equipment were
recurring themes at the Interphex show in Philadelphia last week,
and both were addressed by new equipment...
As single-use technologies become more and more popular for use in
biopharmaceutical manufacturing, Pall is following market demands
bolstering its product line by adding a number of disposable
products to its portfolio.
US-based firm Xcellerex yesterday announced it has completed the
second half of a $20m (€15.4m) financing deal, raising $11m to
speed up commercialisation of its innovative disposable
manufacturing technology for vaccines and biotherapeutics.
Millipore has introduced a new disposable product - NovaSeal - that
ties in with a shift in the bioprocess manufacturing market to the
use of disposable assemblies to shorten production cycles for
drugs.
Millipore has introduced a new container film - PureFlex - that
ties in with the trend towards increasing use of disposable
products within the bioprocessing sector.
Fisher Biosciences's HyClone business has partnered with Alfa Laval
to provide disposable bioprocessing systems for Haemacure's new
manufacturing facility for biological adhesives - one of the first
major installations of...
